Skip to content

Eli Lilly LLY Balance Sheet Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$5.28B+70.8%$7.27B+122%$9.79B+191%$3.38B+4.7%$3.09B+25.7%
$18.43B+53.1%$17.76B+61.4%$16.11B+56.5%$14.17B+28.5%$12.04B+52.6%
$14.49B+56.1%$13.7B+82.0%$12.22B+65.4%$11.02B+72.3%$9.28B+54.6%
$3.76B+40.0%$3.59B+54.2%$3.4B+51.8%$3.15B$2.69B
$8.46B+59.7%$8.18B+106%$7.27B+80.3%$6.51B$5.3B
$2.27B+75.1%$1.93B+58.2%$1.55B+38.9%$1.35B$1.3B
$13.63B-7.0%$14.32B+71.6%$20.25B+145%$18.02B+152%$14.65B+131%
$11.8B
$54.84B+32.9%$55.63B+69.9%$62.07B+97.6%$49.85B+65.1%$41.26B+63.8%
$26.54B+43.7%$24.68B+44.3%$22.32B+38.0%$20.53B+38.4%$18.47B+35.6%
$6.13B+6.2%$5.9B+2.2%$5.9B+2.2%$5.77B0.0%$5.77B+16.8%
$7.37B+22.7%$6.52B+5.8%$6.45B-1.4%$5.91B-11.0%$6.01B-11.1%
$11.35B+32.4%$9.96B+24.5%$8.96B+21.2%$9.43B+41.7%$8.57B+52.2%
$7.23B+19.0%$6.99B+22.2%$6.43B+25.6%$6.23B+26.9%$6.07B+29.0%
$3.12B-3.3%$2.8B-12.9%$2.81B-12.2%$3.21B+11.5%$3.22B+4.4%
$116.58B+30.4%$112.48B+42.9%$114.94B+52.0%$100.92B+40.4%$89.39B+39.8%
$5.03B+46.1%$5.38B+66.6%$4.26B+47.7%$4.08B+39.3%$3.44B+39.1%
$1.36B+22.0%$2.38B+13.4%$1.97B+15.4%$1.3B+11.5%$1.11B+31.9%
$4B-0.4%$1.64B-68.0%$1.63B-21.3%$5.72B+10.9%$4.02B+143%
$5.29B-14.4%$5.88B+426%$9.44B+143%$6.96B+99.0%$6.18B+47.4%
$36.63B+21.8%$35.23B+24.1%$40.14B+62.7%$39.02B+43.9%$30.07B+61.7%
$39.37B+14.1%$40.87B+43.3%$40.87B+40.7%$34.18B+44.0%$34.5B+40.5%
$4.09B+78.5%$3.97B+14.1%$3.78B+68.6%$2.34B-5.1%$2.29B+0.8%
$48.74B+12.1%$50.71B+40.6%$50.94B+39.1%$43.55B+40.0%$43.47B+34.0%
$590M-0.4%$590M-0.3%$591.4M-0.4%$592M-0.4%$592.6M-0.3%
$6.92B+0.2%$7.35B-1.3%$7.23B-1.5%$7.09B-1.7%$6.91B-1.4%
$29.51B+95.5%$24.47B+80.7%$22.25B+63.3%$17.38B+31.9%$15.1B+20.3%
-$2.83B+24.9%-$2.88B+33.4%-$3.21B+25.0%-$3.72B+15.1%-$3.77B+12.2%
$31.2B+97.9%$26.54B+85.9%$23.79B+67.1%$18.27B+34.7%$15.76B+23.0%
$116.58B+30.4%$112.48B+42.9%$114.94B+52.0%$100.92B+40.4%$89.39B+39.8%
$5.28B+70.8%$7.27B+122%$9.79B+191%$3.38B+4.7%$3.09B+25.7%
$214M+196%$147M-44.7%$271.5M+102%$68.8M$72.4M
$2.75B+39.7%$2.4B+5.5%$3.35B+90.7%$3.04B+48.0%$1.97B-7.6%
-$37M-26.3%-$43M+31.6%$38.4M+152%$1.4M-$29.3M
$2.75B+39.7%$2.4B+5.5%$3.35B+90.7%$3.04B+48.0%$1.97B-7.6%
$7.23B+19.0%$6.99B+22.2%$6.43B+25.6%$6.23B+26.9%$6.07B+29.0%
$11.35B+32.4%$9.96B+24.5%$8.96B+21.2%$9.43B+41.7%$8.57B+52.2%
$7.37B+22.7%$6.52B+5.8%$6.45B-1.4%$5.91B-11.0%$6.01B-11.1%
$3.12B-3.3%$2.8B-12.9%$2.81B-12.2%$3.21B+11.5%$3.22B+4.4%
$7.23B+19.0%$6.99B+22.2%$6.43B+25.6%$6.23B+26.9%$6.07B+29.0%
$7.23B+19.0%$6.99B+22.2%$6.43B+25.6%$6.23B+26.9%$6.07B+29.0%
$1.36B+22.0%$2.38B+13.4%$1.97B+15.4%$1.3B+11.5%$1.11B+31.9%
$1.36B+22.0%$2.38B+13.4%$1.97B+15.4%$1.3B+11.5%$1.11B+31.9%
$8.7B+131%$8.46B+32.2%$5.22B-6.5%$5.08B+19.5%$3.77B-10.2%
$17.55B+51.9%$17.38B+50.6%$17.62B+41.8%$14.54B+16.8%$11.55B+22.5%
$17.55B+51.9%$17.38B+50.6%$17.62B+41.8%$14.54B+16.8%$11.55B+22.5%
$43.37B+12.6%$42.73B+22.8%$42.51B+36.6%$39.9B+38.1%$38.52B+46.9%
$3.01B0.0%$3.01B0.0%$3.01B0.0%$3.01B0.0%$3.01B0.0%
$6.92B+0.2%$7.35B-1.3%$7.23B-1.5%$7.09B-1.7%$6.91B-1.4%
$590M-0.4%$590M-0.3%$591.4M-0.4%$592M-0.4%$592.6M-0.3%
$5.29B-1.5%$5.88B+44.7%$6.29B+62.3%$5.68B+62.6%$5.37B+28.2%
$5.28B+70.8%$7.27B+122%$9.79B+191%$3.38B+4.7%$3.09B+25.7%
$3.01B0.0%$3.01B0.0%$3.01B0.0%$3.01B0.0%$3.01B0.0%
$4B-0.4%$1.64B-68.0%$1.63B-21.3%$5.72B+10.9%$4.02B+143%
$3.76B+40.0%$3.59B+54.2%$3.4B+51.8%$3.15B$2.69B
$13.63B-7.0%$14.32B+71.6%$20.25B+145%$18.02B$14.65B

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Eli Lilly's total assets?
Eli Lilly (LLY) holds $116.58B in total assets, up 30.4% year over year.
How much debt does Eli Lilly have?
Eli Lilly carries $43.4B in total debt against $31.2B of shareholders' equity, a debt-to-equity ratio of 1.39.
How much cash does Eli Lilly have?
Eli Lilly holds $5.3B in cash and equivalents.
Can Eli Lilly cover its short-term obligations?
Its current ratio is 1.50 — current assets exceed current liabilities.
Where does Eli Lilly's balance sheet data come from?
Every line is extracted from Eli Lilly's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.